Opioid Therapies and Cytochrome P450 Interactions

被引：48

作者：

Gudin, Jeffrey ^{[1
]}

机构：

[1] Englewood Hosp & Med Ctr, Pain Management & Wellness Ctr, Englewood, NJ 07631 USA

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2012年 / 44卷 / 06期

关键词：

Adverse drug reactions; cytochrome P450; CYP3A4; CYP2D6; drug-drug interactions; inhibitor; inducer; metabolism; prodrug; substrate; opioids; DRUG-DRUG INTERACTIONS; ST-JOHNS-WORT; CAFFEINE METABOLISM; PHARMACOGENETICS; INHIBITION; CYP2D6; PAIN; VARIABILITY; HYDROCODONE; OXYMORPHONE;

D O I：

10.1016/j.jpainsymman.2012.08.013

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Adverse drug reactions are common and associated with substantial economic and human costs. Particularly among older adult populations, preventable adverse drug reactions are often caused by drug-drug interactions. All analgesics have side effect profiles and many have known drug-drug interactions. Opioids are recognized as a necessary option for managing moderate-to-severe pain, yet many opioid side effects can be enhanced by metabolic interactions within the liver, involving other drugs, diseases, or genetics. J Pain Symptom Manage 2012; 44: S4-S14. (C) 2012 U. S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

引用

页码：S4 / S14

页数：11

共 50 条

[31] Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase
Guengerich, F. Peter
Martin, Martha V.
Sohl, Christal D.
Cheng, Qian
NATURE PROTOCOLS, 2009, 4 (09) : 1245 - 1251
[32] Cytochrome p450 recognition sites for NADPH cytochrome p450 reductase
Dai, R
Robinson, RC
Friedman, FK
BIOPHYSICAL JOURNAL, 1996, 70 (02) : SU162 - SU162
[33] Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
Cho, Hyun-Jong
Yoon, In-Soo
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
[34] Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450
Miyamoto, Masayoshi
Yamashita, Taku
Yasuhara, Yuki
Hayasaki, Akinori
Hosokawa, Yukari
Tsujino, Hirofumi
Uno, Tadayuki
CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (04) : 286 - 294
[35] Protein/Protein Interactions in the Human Cytochrome P450 System
Burris-Hiday, Sarah
Scott, Emily
FASEB JOURNAL, 2020, 34
[36] Drug interactions casebook: The cytochrome P450 system and beyond
Heinrichs, DW
JOURNAL OF NERVOUS AND MENTAL DISEASE, 2006, 194 (04) : 307 - 307
[37] Conformational selectivity in cytochrome P450 redox partner interactions
Hollingsworth, Scott A.
Batabyal, Dipanwita
Nguyen, Brian D.
Poulos, Thomas L.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (31) : 8723 - 8728
[38] Protein/protein interactions in the human cytochrome P450 system
Burris-Hiday, Sarah D.
Scott, Emily E.
FASEB JOURNAL, 2022, 36
[39] Fluoxetine metabolism and pharmacological interactions: The role of cytochrome P450
Mandrioli, R
Forti, GC
Raggi, MA
CURRENT DRUG METABOLISM, 2006, 7 (02) : 127 - 133
[40] Cytochrome P450 and its role in veterinary drug interactions
Trepanier, Lauren A.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2006, 36 (05) : 975 - +

← 1 2 3 4 5 →